% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Fedosov:154031,
author = {Fedosov, Dmitry and Dao, M. and Karniadakis, G. E. and
Suresh, S.},
title = {{C}omputational biorheology of human blood flow in health
and disease},
journal = {Annals of biomedical engineering},
volume = {42},
number = {2},
issn = {0191-5649},
address = {Dordrecht [u.a.]},
publisher = {Springer Science + Business Media B.V},
reportid = {FZJ-2014-03445},
pages = {368-387},
year = {2014},
abstract = {Hematologic disorders arising from infectious diseases,
hereditary factors and environmental influences can lead to,
and can be influenced by, significant changes in the shape,
mechanical and physical properties of red blood cells
(RBCs), and the biorheology of blood flow. Hence, modeling
of hematologic disorders should take into account the
multiphase nature of blood flow, especially in arterioles
and capillaries. We present here an overview of a general
computational framework based on dissipative particle
dynamics (DPD) which has broad applicability in cell
biophysics with implications for diagnostics, therapeutics
and drug efficacy assessments for a wide variety of human
diseases. This computational approach, validated by
independent experimental results, is capable of modeling the
biorheology of whole blood and its individual components
during blood flow so as to investigate cell mechanistic
processes in health and disease. DPD is a Lagrangian method
that can be derived from systematic coarse-graining of
molecular dynamics but can scale efficiently up to
arterioles and can also be used to model RBCs down to the
spectrin level. We start from experimental measurements of a
single RBC to extract the relevant biophysical parameters,
using single-cell measurements involving such methods as
optical tweezers, atomic force microscopy and micropipette
aspiration, and cell-population experiments involving
microfluidic devices. We then use these validated RBC models
to predict the biorheological behavior of whole blood in
healthy or pathological states, and compare the simulations
with experimental results involving apparent viscosity and
other relevant parameters. While the approach discussed here
is sufficiently general to address a broad spectrum of
hematologic disorders including certain types of cancer,
this paper specifically deals with results obtained using
this computational framework for blood flow in malaria and
sickle cell anemia.},
cin = {IAS-2 / ICS-2},
ddc = {610},
cid = {I:(DE-Juel1)IAS-2-20090406 / I:(DE-Juel1)ICS-2-20110106},
pnm = {451 - Soft Matter Composites (POF2-451)},
pid = {G:(DE-HGF)POF2-451},
typ = {PUB:(DE-HGF)16},
UT = {WOS:000331976300011},
doi = {10.1007/s10439-013-0922-3},
url = {https://juser.fz-juelich.de/record/154031},
}